Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
International: Page 2
Rubicon Organics Obtains Key Certification for International Export
The company’s dried cannabis products are now compliant with the World Health Organization’s guidelines on GACP medicinal plants.
Tilray Expands Medical Cannabis Portfolio in Germany
The company launched new cannabis extract products and formulations.
Tilray Brands Enhances Global Cannabis Supply Chain
The company increased its industry-leading capacity to meet global demand, driving growth across Canada and Europe.
Village Farms International Commences Sales at Leli Holland Subsidiary in Netherlands
The company meets previous guidance on the commencement of sales with deliveries of the first flower harvest to coffee shops.
High Tide to Enter German Medical Cannabis Market Through Acquisition of Purecan GmbH
The acquisition will give High Tide a majority stake in Purecan’s profitable operations.
Empowering the Next Generation: Aurora Cannabis Announces German Internship Program
The cannabis company launched the program at its manufacturing facility in Leuna, Germany, to cultivate future leaders in the medical cannabis industry.
Flora Growth Appoints Sammy Dorf, Verano Co-Founder, as Executive Chairman
Adds Verano Co-Founder to its Board as it Accelerates its Entry into the THC-Infused Beverage Market
Flora Growth Enters Supply Agreement With Curaleaf Targeting $450 Million German Cannabis Market
The agreement will facilitate the importation of high-quality medical cannabis products into Germany
Curaleaf Denies Having Supply Agreement With Flora Growth for German Market
Florida-based Flora Growth issued a press release indicating it partnered with Curaleaf to bring medical cannabis products to the European market.
Puro Announces Strategic Investment from Te Rūnanga o Kaikōura
The partnership will create employment opportunities and enhance community well-being.
Curaleaf Issues Report on Illicit Online Cannabis Sales, Urges UK Government Action
The international cannabis company’s report reveals serious health risks of mold, lead and synthetic cannabinoids in unregulated cannabis.
MedCana Subsidiary in Colombia Enters Negotiations With Australian Firm for Pharma Cannabis Supply
The company is poised to enter into a supply agreement with $1.2 million to $2.4 million annually.
Previous Page
Page 2 of 63
Next Page